October 10, 2018 / 1:41 PM / 7 days ago

BRIEF-Ionis Pharmaceuticals Enters New Collaboration With Partner

Oct 10 (Reuters) - Ionis Pharmaceuticals Inc:

* IONIS ENTERS NEW COLLABORATION WITH PARTNER TO DEVELOP IONIS-FB-L RX FOR COMPLEMENT-MEDIATED DISEASES

* IONIS PHARMACEUTICALS INC - TRANSACTION VALUED AT UP TO $760 MILLION, INCLUDING $75 MILLION UPFRONT PAYMENT, PLUS ROYALTIES UP TO 20%

* IONIS PHARMACEUTICALS INC - PLANNED PHASE 2 PROGRAM TO BEGIN IN EARLY 2019 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below